Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: Implications for cellular cardiomyoplasty  by Teng, Carolyn J. et al.
M
i
f
C
Evolving Technology Teng et al
6
ETassive mechanical loss of microspheres with direct
ntramyocardial injection in the beating heart: Implications
or cellular cardiomyoplasty
arolyn J. Teng, MD, Jun Luo, MD, Ray C. J. Chiu, MD, PhD, and Dominique Shum-Tim, MD, MSc
O
i
r
h
a
M
c
r
w
a
T
m
R
s
p
v
d
t
h
C
c
b
S
a
m e
f
d
i
c
c
o
t
r
o
aFrom the Division of Cardiac Surgery,
McGill University, Montreal, Quebec, Can-
ada.
Supported by the Heart and Stroke Foun-
dation of Quebec (HSFQ) and Fonds de la
Recherche en Santé du Quebec (FRSQ).
Presented in part at the Annual Congress of
The American Heart Association, Dallas,
Tex, Nov 14, 2005.
Received for publication Dec 8, 2005; re-
visions received April 11, 2006; accepted
for publication May 24, 2006.
Address for reprints: Dominique Shum-
Tim, MD, Division of Cardiac Surgery, The
Montreal General Hospital, MUHC, 1650
Cedar Ave, Suite C9-169, Montreal, Que-
bec, Canada H3G 1A4 (E-mail: dshumtim@
yahoo.ca).
J Thorac Cardiovasc Surg 2006;132:628-32
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic Surgery
Dr Tengs
doi:10.1016/j.jtcvs.2006.05.034
28 The Journal of Thoracic and Cardiobjective: Direct intramyocardial injection is a common route of donor cell admin-
stration for myocardial cell therapy. Studies have demonstrated a significant and
apid loss of implanted cells, which is thought to be biologically caused. We
ypothesized that mechanical loss of cells from the contracting myocardium might
ctually be the main culprit.
ethods: Intramyocardial injections of fluorescent microspheres (10 m) were
arried out in both small and large animal models. The hearts of Lewis rats (250-350 g)
eceived 3  106 microspheres injected into the left ventricular myocardium. Rats
ere divided evenly between two experienced operators. The nonbeating (n  2)
nd beating (n  5) hearts of piglets (7.5-7.8 kg) received 3  106 microspheres.
he hearts were excised within 10 minutes, and the microspheres retained in the
yocardium were quantified with fluorescent flow cytometry.
esults: In the beating-heart rat model, the microsphere retention rates after a
ingle injection were similar with and without purse-string occlusion of needle
uncture sites and slightly lower than after multiple site injections (6.19%  4.05%
s 5.44%  5.66% vs 8.83%  3.29%). There were no significant operator-
ependent differences. The retention rates in beating porcine hearts were higher than
hose in the rats (P  .05) but markedly lower than those in nonbeating porcine
earts (11.1% vs 67.4%).
onclusion: Mechanical leakage and washout may account for a major portion of
ell loss after cell implantation, and efforts aimed at reducing mechanical loss in the
eating heart may yield a greater benefit than those targeting biologic loss alone.
urvival of cells after intramyocardial injection is crucial to the efficacy of
therapeutic cell transplantation. In an attempt to increase the number of cells
surviving after injection, many researchers have targeted cell deaths (due to
poptosis, ischemia, free radical formation, etc). However, recent studies suggest a
assive loss of cells in the first minutes after injection.1-4 I  light of the early tim
rame in which this loss takes place, it is unlikely to be accounted for solely by cell
eath.
Cells can be delivered in a variety of ways, and one of the most common methods
s direct intramyocardial injection. The technique of injection may result in me-
hanical loss, in the form of cells leaking from the site through the puncture hole,
ells retained in the syringe, or vascular washout. Because the heart differs from
ther organs in that it is constantly contracting, it is possible that this may contribute
o the mechanical loss by squeezing the injected cells out of the myocardium. As a
esult, the cells retained in the myocardium immediately postinjection represent
nly a fraction of those initially implanted. It is from this subset that biologic loss
nd gain, through cell death and proliferation, can then affect the quantity of
urviving cells.
vascular Surgery ● September 2006
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Teng et al Evolving Technology
ETSmall animal models have been used extensively to
xamine the effects of cellular implantation in the myocar-
ium. Because of the small size of the heart, relative thin-
ess of the ventricular wall, and rapid cardiac contractions,
echanical loss may be more pronounced in smaller ani-
als than in larger animals. Thus examining mechanical
oss in the small animal model is relevant to much of the
asic science studies being done, whereas the larger animal
odel may be more clinically relevant.
Many studies have attempted to limit the biologic loss
rom cell death by focusing on measures such as antiapop-
otic5,6 or angiogenic gene therapies,7 as well as heat sho
nd anti–free radical treatments.8 Although limiting cel
eath may be important, if the initial decrease in cells from
echanical loss leaves only a fraction of the cells within the
yocardium postinjection, then keeping this small fraction
live may not be as effective as simply retaining more cells
y limiting mechanical loss. Many studied have focused on
he biologic component of cell loss; however, few have
ddressed the contribution of mechanical loss in determin-
ng the final number of surviving cells postimplantation.
hus the objectives of this study were as follows: (1) to
uantify mechanical loss during direct intramyocardial in-
ection, (2) to compare small and large animal models, (3) to
uantify the contribution of myocardial contraction to me-
hanical loss, and (4) to define a model for quantifying
echanical cell loss that may be used as a tool to test and
evelop better techniques of cell implantation for myocar-
ial regenerative therapy.
ethods
ll experiments were performed in accordance with the guidelines
et forth by the Canadian Council on Animal Care.
Each aliquot of microspheres (from Interactive Medical Tech-
ologies, Ltd (Irvine, Calif) contained 3 million microspheres
3.75%) measuring 10 m in diameter and suspended in 150 L
r 800 L (for rat or pig injections respectively) saline solution
ith 0.05% polysorbate 80 and 0.01% thimerosal.
at Heart Intramyocardial Injections
ale Lewis rats weighing 250 to 350 g (n 36) were placed under
eneral anesthesia with 5% isoflurane in an induction chamber.
he rats were then intubated with an 18-gauge catheter and me-
hanically ventilated. Anesthesia was maintained with 3% isoflu-
ane. A left thoracotomy was performed to provide access to the
eart. The pericardium was entered, and an injection of 100 L
icrosphere solution was prepared with a 0.5-mL tuberculin sy-
inge and a 28-gauge needle. In the first group of rats (n  12), a
ingle injection directly into the myocardium was used to admin-
ster the microspheres. For the second group (n  12), a U-stitch
f 6-0 Prolene (Ethicon, Inc, Somerville, NJ) was made in the
picardium before injection. The injection was made with the
eedle passing through the center of the U-stitch, and the epicar-
ial opening of the needle tract was closed by tying down the stitch
s the needle was withdrawn. The third group of rats (n  12) A
The Journal of Thoraciceceived 100 L of solution divided into 3 intramyocardial injec-
ions given in separate areas on the anterolateral wall of the heart
ith the same syringe. After each injection, the surgeons would
ecord the subjective assessment of how successful the injection
as on a scale of 0 to 10 (0 being an injection where the surgeon
elt that all of the microsphere solution was injected too deeply or
uperficially, and 10 being an injection where the surgeon felt that
ll of the microsphere solution was injected perfectly into the
yocardium). The number of rats in each group was divided
venly between the two surgeons.
Rat hearts were removed within 10 minutes after injection.
earts were flushed with phosphate-buffered saline solution
hrough the aorta in a retrograde fashion to remove excess micro-
pheres that might have been retained in the ventricular chamber
ather than in the myocardium. The surface of each heart was also
ashed in phosphate-buffered solution. The whole heart was then
ndividually placed in a 15-mL tube and sent to Interactive Med-
cal Technologies Laboratory for processing. In addition, each
yringe used for injection was flushed with saline solution, and the
aline flush was collected in the respective vials from which each
liquot was drawn. Each of these vials was also sent back to
nteractive Medical Technologies Laboratory to count the number
f microspheres that had not been injected. Given that 3 million
icrospheres were originally present in each vial, subtracting the
um of the microspheres left in a vial plus the number of micro-
pheres left in the syringe from the initial 3 million would give the
ctual number of microspheres injected. Both the tissue samples
nd vials of unused microspheres were processed for immediate
hipment to Interactive Medical Technologies, Investigative Part-
er Services, where individual tissue samples were digested in
lkaline solution. Microspheres were then collected on a filter,
esuspended, and quantified with fluorescent flow cytometry.
orcine Heart Intramyocardial Injections
andracer  Yorkshire  Duroc pigs weighing 7.5 to 7.8 kg were
laced under general anesthesia, intubated, and mechanically ven-
ilated. A sternotomy was performed to provide access to the heart.
or the beating-heart group (n  5), the pericardium was entered
nd an injection of 700 L of microsphere solution was prepared
ith a 1.0-mL tuberculin syringe and a 28-gauge needle. A single
ose of orange microspheres was injected directly into the myo-
ardium of the left ventricle. For the multiple injection samples,
00 L of violet microsphere solution was divided into three
ntramyocardial injections given in separate areas on the left ven-
ricle with the same syringe. In the nonbeating-heart group (n 2),
he heart was extracted from the chest cavity of the pig, and a
ingle injection of microspheres was carried out directly into the
rrested myocardium of the left ventricle.
The porcine hearts were removed within 10 minutes after
njection. The left ventricle was excised and placed in a 50-mL
ube and sent to Interactive Medical Technologies Laboratory for
rocessing. The quantity of microspheres in the tissue was deter-
ined and calculated as described previously. The orange and
iolet microspheres were counted separately.
tatistical Analysis
ll values were expressed as mean  standard error of mean.
nalysis of variance (F-test) was used to calculate the statistical
and Cardiovascular Surgery ● Volume 132, Number 3 629
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ETignificance of differences between the means of groups. To com-
ine the data obtained from the two operators, the tests for nor-
ality and for equal variance were performed. When analysis of
ariance was significant, post hoc analysis with the Bonferroni
orrection and selected t tests were to be performed.
esults
at Heart Intramyocardial Injections
here was no difference in the rate of microsphere retention
etween the two operators who performed the injections
Figure 1). Also of note, there was poor correlation bet
he operators’ subjective ratings of the quality of injection at
he time of implantation and the rates of microsphere reten-
ion (Figure 2).
Because the tests for the normality and for equal variance
or the data obtained from the two operators were positive,
hey were combined for further analysis. The combined mi-
rosphere retention rates were similar in the single-injection
roup and the suture ligation group (6.19%  4.05% vs
.44%  5.66%, respectively). The multiple-injection group
ad a slightly higher retention rate (8.83%  3.29%; Figure 1)
lthough these differences did not reach statistical signifi-
ance according to analysis of variance.
orcine Heart Intramyocardial Injections
he percentage of microspheres retained in the porcine
eart post injection was significantly higher than in the30 The Journal of Thoracic and Cardiovascular Surgery ● Septeat heart (P  .05; Figure 3). The microsphere retenti
ates in the porcine hearts also showed a trend towards a
igher retention rate with the multiple-injection method;
owever, such a difference did not reach statistical
ignificance.
In the beating heart, the percentage of microspheres
etained was markedly less than in the nonbeating heart
Figure 4). In the porcine hearts, the microsphere reten
ate in the noncontracting heart was almost 7 times that in
he beating heart.
iscussion
ecently, numerous basic and clinical studies have indi-
ated that myocardial implantation of various stem cells and
rogenitor cells may improve cardiac function in hearts with
yocardial damage. Among many unanswered issues in
ellular cardiomyoplasty today is the question of how to
etermine the optimal quantity of cells to be implanted to
btain the maximal clinical benefits. To elucidate such a
ose-response relationship in myocardial cell therapy, the
uestions of implantation technique and the subsequent
ntramyocardial cell retention and survival rates need to be
xamined. In many reported studies, the number of surviv-
ng cells appeared to be quite small, such that often in the
istologic sections surprisingly few labeled implanted cells
ere found in various experimental models.
Figure 1. Microsphere retention rates in beating-
heart rat model. Combined indicates that data
from operators 1 and 2 are pooled together.
Figure 2. Beating-heart rat model, testing possi-
ble role of implant skills on microsphere reten-
tion rate.mber 2006
i
i
o
c
f
n
a he
c
t
i
c
c
s
a
c
a
t
i
t
a
w
d
p
i
l rsor
c
h
7
h
2
c
a
t
fi
n
d
q
r
w
d
g
fi d
c
s
i
d
i
i
a
o s.
T
c
b
t
c
f
h
u
M to
d
u
t
t
o
u
w
t
t
t
N
F
i
F
l
Teng et al Evolving Technology
ETOne of the most common techniques of cell implantation
nto the myocardium in both experimental and clinical stud-
es is the direct injection of the cells through the epicardium,
r through the endocardium in large animal models and
ardiac patients with a transvascular catheter approach. In a
ew quantitative studies in small animal models, very low
umbers of cells appeared to have survived days and weeks
fter the implantation.1 The prevailing assumption for t
ause of such a low cellular survival rate is the death of
hese cells after implantation. Because these cells are often
mplanted into an ischemic myocardium, inadequate myo-
ardial blood perfusion has been thought to be a major
ulprit. Other important mechanisms of biologic cell death
uggested include the damage caused by free radicals and
poptosis. Thus numerous studies have been carried out to
ounter such pathogenic processes to minimize cell death
nd salvage a larger portion of implanted cells.2-8 Implicit in
hese studies was the assumption that virtually all the cells
njected into the myocardium were retained in situ and were
hen gradually depleted by various biologic processes.
There is, however, increasing evidence that such an
ssumption may not be valid. In a number of studies in
hich the quantity of implanted cells within the myocar-
ium was studied sequentially, it was shown that a large
ortion of the cell loss occurred shortly after the cells were
njected directly into the myocardium. Suzuki and col-
eagues4 found that only 44.8% of skeletal muscle precu
ells survived 10 minutes after implantation, a figure that
ad steadily decreased to 14.6% by 24 hours and to 7.9% by
2 hours. Proliferation of the surviving cells began after 24
ours, increasing cell numbers to 15.5% at 24 hours and
4.4% at 72 hours. Thus there seems to be three phases of
hanges in cell numbers after implantation: phase I, a rapid
nd massive loss of cells immediately after cell implanta-
ion, followed by phase II, a period of gradual decay, and
nally in some cases phase III, with some increase in cell
igure 3. Microsphere retention rates in small animal (rat) versus
arge animal (pig) beating-heart models.umbers. We postulate that these three phases are caused by r
The Journal of Thoracicifferent mechanisms. The phase I rapid decrease in the
uantity of implanted cells is likely to be mechanical, a
esult of cell leakage through the injection tract or a rapid
ashout through the coronary venous system, which was
isrupted by the needle puncture allowing entry into the
eneral circulation. This scenario is consistent with the
ndings of many investigators9,10 that the implanted labele
ells are often found in large quantities in various organs,
uch as the lung and the liver. The phase II gradual decay of
mplanted cells is likely to be biologic in nature, as has been
emonstrated in the studies quoted here. The phase III
ncrease in cell number is likely to be due to the divisions of
mplanted stem cells or progenitor cells.
The hypothesis that the phase I and phase II cell losses
re based on different mechanisms is consistent with the
bservations reported by Muller-Ehmsen and coworker1
hey found that early after injection the number of retained
ells correlated linearly with the number of cells injected,
ut at the phase II period there was no correlation between
he number of injected cells and the number of surviving
ells. Different kinetics of cell loss strongly suggests dif-
erent underlying mechanisms.
The magnitude of microsphere retention rate reported
ere is lower than those reported by some other studies that
sed cell markers (eg, Suzuki and colleagues,4 44.8%, and
uller-Ehmsen and coworkers,1 57%). This may be due 
ifferent experimental models and quantitating techniques
sed. It is possible that cells injected into noncontractile scar
issue may be retained better than those injected into con-
ractile border zone of myocardial infarction. The technique
f quantitating the fluorescent microspheres in the tissue
sed in our study has been validated in numerous reports in
hich this technique has been used to study myocardial
issue blood perfusion. Certainly the microspheres, unlike
he cells, do not have surface adhesion molecules or plas-
icity in shape, which may play a role in retention rate.
evertheless, the rationale for using microspheres that cor-
igure 4. Microsphere retention rates in beating versus nonbeat-
ng porcine hearts.espond closely in size to the implanted cells is to remove
and Cardiovascular Surgery ● Volume 132, Number 3 631
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ETompletely the possibility of cell death from biologic fac-
ors, thus isolating the mechanical mechanism of cell leak-
ge and washout.
Our rat study was carried out because this small animal
odel has been used extensively in basic research on myo-
ardial cell therapy. The very low retention rate of micro-
pheres in the rat hearts relative to that seen in the porcine
odel (Figure 3) may be related both to the tech
hallenge and to physiologic characteristics of dealing with
very small rat heart with thin myocardium that is con-
racting rapidly during and after implantation. Our finding
hat the purse-string suture on the epicardium around the
uncture hole, which was tied immediately on removal of
he needle, made no significant difference to the retention
ate suggests that the backward leakage played a relatively
inor role. This in turn suggests that washout of the im-
lanted microspheres, perhaps assisted by the myocardial
ontractile force, played a major role in their loss from the
njection site. The injections of microspheres were carried
ut by two cardiac surgery residents with training in surgi-
al techniques, both of whom had experience for nearly a
ear in the research laboratory in injecting cells into rat
yocardium (Figure 1). There was no difference betw
ata obtained by these two operators. That their subjective
udgment regarding the technical quality of cell implant in
ach animal correlated poorly with the quantity of micro-
pheres lost is also of interest, suggesting that this massive
oss may not have been due primarily to technical difficul-
ies (Figure 2).
The large animal study was carried out because the size
f the porcine heart, the myocardial thickness, and the
ardiac contraction rate are closer to those of the human
eart. Thus the data obtained may be more relevant to
uman clinical implantations. The importance of myocar-
ial contractile force squeezing these microspheres to leak
ack or to be washed out was fully illustrated when these
icrospheres were injected into noncontractile porcine
yocardium (Figure 4). Although the sample size 
mall, the observation that myocardial microsphere reten-
ion in a noncontracting myocardium was 7 times that for a
imilar heart in active contraction strongly supports this
otion.
Our finding that multiple small bolus injections, and
articularly injection into a noncontracting myocardium,
32 The Journal of Thoracic and Cardiovascular Surgery ● Septel
mproved the retention rate of cells could be clinically
elevant. For example, a patient undergoing cardiopulmo-
ary bypass and cardioplegic arrest would have a motion-
ess myocardium. Thus when cell therapy is to be combined
ith a surgical procedure such as on-pump coronary bypass
urgery, it could be advantageous to implant the cells during
ardioplegia, rather than after removal of aortic crossclamp.
o confirm this possible strategic advantage, however, fur-
her studies are required to ascertain that the microspheres
re not rapidly washed out on recovery of cardiac contrac-
ions. Thus this experimental model of using microspheres
o study the mechanical leakage could be a simple and
seful tool to further improve cell transplantation tech-
iques, optimizing application in clinical patients.
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